Video: Bristol-Meyers Squibb - A Takeover Target Again?

Bristol-Meyers's Plavix is the world's third-best selling drug. Potential suitors include Sanovi-Aventis, Pfizer, AstraZeneca, and GlaxoSmithKline. The UBS sees takeout prospects up to $37/share while Bristol Meyers declines to comment on takeover talk.